{
  "title": "Campaign Page",
  "isCampaign": true,
  "hero": {
    "title": "<strong>The benefits of long-term proteasome inhibition with NINLARO<sup>&reg;</sup> (ixazomib)</strong>",
    "subheading": "<p>NINLARO is the first efficacious, all-oral therapy for patients with multiple myeloma after one prior therapy.</p>",
    "class": "hero--alt",
    "image": {
      "mobile": "images/lighthouse-mobile.png",
      "tablet": "images/lighthouse-tablet.png",
      "desktop": "images/lighthouse-desktop.png"
    }
  },
  "navPrimary": {
    "items": [
      {
        "name": "Request a Rep",
        "link": "t7.0-contact-a-rep.html",
        "className": "btn btn--sm color--secondary"
      }
    ]
  }
}